Platelet Rich Plasma Market
Growth Factors of Platelet Rich Plasma Market
The platelet rich plasma market size was valued at USD 337.2 billion in 2023, and the market is now projected to grow from USD 387.8 billion in 2024 to USD 1048.6 billion by 2032, exhibiting a CAGR of 15.3% during the forecast period of 2024-2032.
Pandemic impacted the market boom negatively, due to disruptions in shipping chains. Lockdown restrictions substantially impacted affected person visits for orthopedic, wound care, cosmetic, and neurological treatments. A survey with the aid of the National Institutes of Health located that 60.9% of sufferers ignored appointments and did no longer preserve touch with experts in Italy, reducing using these treatments and affecting sales of related merchandise. However, a resurgence in clinic and ASC visits for those treatments helped the market get better to pre-pandemic levels in 2022, probably bringing it again to pre-pandemic boom levels from 2023 to 2030.
PRP merchandise is gaining reputation amongst sufferers stricken by musculoskeletal or sports accidents, affecting muscle tissues, nerves, tendons, joints, cartilage, and spinal discs. PRP is injected into damaged ligaments, stimulating mobile migration and new blood vessel formation, intensifying healing. The rising instances of sports activities accidents will increase the call for such treatments globally.
The market is witnessing a surge within the use of treatments in cosmetic rejuvenation approaches, especially in orthopedics, neurology, cosmetics, and wound care management. These healing procedures are used for wrinkle reduction, sagging skin plumping, deep crease reduction, complexion improvement, and pimples scar reduction. The increasing call for these procedures and their sturdy efficacy is anticipated to force platelet rich plasma market growth.
Comprehensive Analysis of Platelet Rich Plasma Market
The market is segmented into Pure PRP, L-PRP, and Platelet Rich Fibrin (PRF). Pure PRP holds a significant market share in 2022 due to its robust utilization and recent reconstructive care launches. PRF is projected to capture a substantial market share over the forecast period due to its strong application in oral surgery. The market is further divided into orthopedics, neurology, cosmetics, and wound care. The wound care segment is dominant due to the rising cases of multiple injuries and frequent product launches. Orthopedics is a significant market due to their ability to accelerate the healing of damaged joints, ligaments, tendons, and muscles. Cosmetics and neurology also hold a suitable share due to the growing adoption of PRP products to address beauty-related issues. The end user segment is divided into hospitals & ASCs, specialty clinics, and others. Hospitals & ASCs hold a dominant market share due to the preference of patients suffering from chronic and acute wounds and the increasing number of hospitals providing PRP therapy in developing countries like India. Specialty clinics are expected to grow at a lucrative rate due to the growing number of cosmetic procedures in specialty clinics. Home-use kits are projected to account for a suitable market share by 2030.
The North America region lead the platelet rich plasma market share by benefitting a market size of USD 148.9 billion in 2023 due to its robust marketplace presence, FDA approvals, strong healthcare infrastructure, and tremendous product adoption for multiple programs, contributing to its dominance inside the international market.
The marketplace is dominated with the aid of main players like Zimmer Biomet, Arthrex, Inc., and Stryker Corporation, because of their strong product portfolios and increasing geographical presence. These businesses also are worried in strategic sports and expanding their distribution networks, further enhancing their marketplace dominance. Key agencies in the marketplace encompass Isto Biologics, ThermoGenesis Holdings, EmCyte Corporation, Terumo Corporation, and Johnson & Johnson Services.
Crown Aesthetics rebranded its ProGen PRP Advantage product in November 2022 to ProGen PRP Eclipse, claiming it offers steady consequences to meet all customer needs.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2019-2021
Growth Rate CAGR of 15.3% from 2023-2030
Unit Value (USD Million)
Segmentation
By Product
Pure Platelet Rich Plasma (Pure PRP)
Leukocyte-rich Platelet Rich Plasma (L-PRP)
Platelet Rich Fibrin (PRF)
Others
By Application
Orthopedics
Neurology
Cosmetics
Wound Care
Others
By End User
Hospitals & ASCs
Specialty Clinics
Others
By Region
North America (By Product, By Application, By End User, and By Country)
- U.S.
- Canada
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- China
- India
- Japan
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Rest of the Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Key Chronic Diseases, By Key Countries/Region, 2022
- 4.2. Key Industry Developments
- 4.3. Overview of Regulatory Scenario, By Key Regions
- 4.4. Advancements in Platelet Concentrates
- 4.5. Impact of Covid-19 on the Market
- 5. Global Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Pure Platelet Rich Plasma (Pure PRP)
- 5.1.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
- 5.1.3. Platelet Rich Fibrin (PRF)
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Orthopedics
- 5.2.2. Neurology
- 5.2.3. Cosmetics
- 5.2.4. Wound Care
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Pure Platelet Rich Plasma (Pure PRP)
- 6.1.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
- 6.1.3. Platelet Rich Fibrin (PRF)
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Orthopedics
- 6.2.2. Neurology
- 6.2.3. Cosmetics
- 6.2.4. Wound Care
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Pure Platelet Rich Plasma (Pure PRP)
- 7.1.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
- 7.1.3. Platelet Rich Fibrin (PRF)
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Orthopedics
- 7.2.2. Neurology
- 7.2.3. Cosmetics
- 7.2.4. Wound Care
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Pure Platelet Rich Plasma (Pure PRP)
- 8.1.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
- 8.1.3. Platelet Rich Fibrin (PRF)
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Orthopedics
- 8.2.2. Neurology
- 8.2.3. Cosmetics
- 8.2.4. Wound Care
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Pure Platelet Rich Plasma (Pure PRP)
- 9.1.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
- 9.1.3. Platelet Rich Fibrin (PRF)
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Orthopedics
- 9.2.2. Neurology
- 9.2.3. Cosmetics
- 9.2.4. Wound Care
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
- 10.1. Market Analysis, Insights and Forecast – By Product
- 10.1.1. Pure Platelet Rich Plasma (Pure PRP)
- 10.1.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
- 10.1.3. Platelet Rich Fibrin (PRF)
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Orthopedics
- 10.2.2. Neurology
- 10.2.3. Cosmetics
- 10.2.4. Wound Care
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By End User
- 10.3.1. Hospitals & ASCs
- 10.3.2. Specialty Clinics
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2022)
- 11.2. Company Profiles
- 11.2.1. Arthrex, Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Product
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. Isto Biologics
- 11.2.2.1. Overview
- 11.2.2.2. Product
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Zimmer Biomet
- 11.2.3.1. Overview
- 11.2.3.2. Product
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. ThermoGenesis Holdings, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Product
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. Exactech, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Product
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. EmCyte Corporation
- 11.2.6.1. Overview
- 11.2.6.2. Product
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. Stryker
- 11.2.7.1. Overview
- 11.2.7.2. Product
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. Terumo Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Product
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. financials (Based on Availability)
- 11.2.9. Johnson & Johnson Services, Inc.
- 11.2.9.1. Overview
- 11.2.9.2. Product
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook